Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan, FTBI, and Etoposide Prior to Allogeneic Stem Cell Transplant for Advanced Hematological Malignancies
NCT00534430Phase 2Completed
- Sponsor
- City of Hope
- Start
- Feb 2000
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of busulfan, etoposide in leukemia, myelodysplastic syndrome (MDS), sponsored by City of Hope. Started Feb 2000; status: completed.
02
Drugs
busulfanetoposide
03
Conditions
leukemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00534430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534430.